Stem Cell Therapy Market by Cell Source (Bone Marrow, Adipose tissue, iPSCs, Neural, Embryo/Cord Blood derived), Type (Autologous, Allogeneic), Therapeutic Application (Wound & Injury, Musculoskeletal, aGVHD, CVD, Surgery) – 2020s to 2025

$3,850.00$5,850.00

AVAIL 20% DISCOUNT ON PURCHASE OF ANY REPORT
Published on: March 17, 2020
Clear
SKU: GMS-2046 Category:

The Global Stem Cell Therapy Market is expected to hit USD 193.17 million by 2025, rising by 10.51% to CAGR during the forecast period. Factors such as increasing number of scientific research activities focused on utilizing the therapeutic potency of stem cells for disease treatment, and the introduction of stem cell line banking and development of induced pluripotent stem cell (iPSC) lines are driving demand for Stem Cell Therapy Market.

Stem Cell Therapy Market by Cell Source (Bone Marrow, Adipose tissue, iPSCs, Neural, Embryo/Cord Blood derived), Type (Autologous, Allogeneic), Therapeutic Application (Wound & Injury, Musculoskeletal, aGVHD, CVD, Surgery) - 2020s to 2025 1

Stem Cell Therapy Market by Cell Source (Bone Marrow, Adipose tissue, iPSCs, Neural, Embryo/Cord Blood derived), Type (Autologous, Allogeneic), Therapeutic Application (Wound & Injury, Musculoskeletal, aGVHD, CVD, Surgery) - 2020s to 2025 2

Stem Cell Therapy Market by Cell Source (Bone Marrow, Adipose tissue, iPSCs, Neural, Embryo/Cord Blood derived), Type (Autologous, Allogeneic), Therapeutic Application (Wound & Injury, Musculoskeletal, aGVHD, CVD, Surgery) - 2020s to 2025 3

Stem Cell Therapy Market by Cell Source (Bone Marrow, Adipose tissue, iPSCs, Neural, Embryo/Cord Blood derived), Type (Autologous, Allogeneic), Therapeutic Application (Wound & Injury, Musculoskeletal, aGVHD, CVD, Surgery) - 2020s to 2025 4

Stem Cell Therapy Market by Cell Source (Bone Marrow, Adipose tissue, iPSCs, Neural, Embryo/Cord Blood derived), Type (Autologous, Allogeneic), Therapeutic Application (Wound & Injury, Musculoskeletal, aGVHD, CVD, Surgery) - 2020s to 2025 5

Stem Cell Therapy Market by Cell Source (Bone Marrow, Adipose tissue, iPSCs, Neural, Embryo/Cord Blood derived), Type (Autologous, Allogeneic), Therapeutic Application (Wound & Injury, Musculoskeletal, aGVHD, CVD, Surgery) - 2020s to 2025 6

Stem Cell Therapy Market by Cell Source (Bone Marrow, Adipose tissue, iPSCs, Neural, Embryo/Cord Blood derived), Type (Autologous, Allogeneic), Therapeutic Application (Wound & Injury, Musculoskeletal, aGVHD, CVD, Surgery) - 2020s to 2025 7

Stem Cell Therapy Market by Cell Source (Bone Marrow, Adipose tissue, iPSCs, Neural, Embryo/Cord Blood derived), Type (Autologous, Allogeneic), Therapeutic Application (Wound & Injury, Musculoskeletal, aGVHD, CVD, Surgery) - 2020s to 2025 8

1 Global Stem Cell Therapy Market
1.1 Study Objectives
1.2 Market Definition
1.3 Study Scope
1.3.1 Markets Covered
1.3.2 Geographic Scope

2 RESEARCH METHODOLOGY
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data from Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data from Primary Sources
2.1.2.2 Key Industry Insights
2.1.2.3 Breakdown of Primaries
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.2 Top-Down Approach
2.3 Market Breakdown and Data Triangulation
2.4 Research Assumptions

3 Global Stem Cell Therapy Market – Executive Summary
3.1 Market Revenue, Market Size and Key Trends by Company
3.2 Key Trends by type of Application
3.3 Key Trends segmented by Geography

4 Global Stem Cell Therapy Market – Comparative Analysis
4.1 Product Benchmarking – Top 10 companies
4.2 Top 5 Financials Analysis
4.3 Market Value split by Top 10 companies
4.4 Patent Analysis – Top 10 companies
4.5 Pricing Analysis

5 Global Stem Cell Therapy Market – Industry Market Entry Scenario
5.1 Regulatory Framework Overview
5.2 New Business and Ease of Doing business index
5.3 Case studies of successful ventures
5.4 Customer Analysis – Top 10 companies

6 Global Stem Cell Therapy Market – Market Forces
6.1 Introduction
6.2 Market Dynamics
6.2.1 Drivers
6.2.2 Opportunities
6.2.3 Challenges
6.3 Porters Analysis of Market
6.3.1 Bargaining power of suppliers
6.3.2 Bargaining powers of customers
6.3.3 Threat of new entrants
6.3.4 Rivalry among existing players
6.3.5 Threat of substitutes

7 Global Stem Cell Therapy Market – Strategic Analysis
7.1 Value Chain analysis
7.2 Product Life Cycle
7.3 Supplier and distributor analysis (Market share and product dealing strategies)

8 Global Stem Cell Therapy Market – By Type (Market Size – & million/billion)
8.1 Allogeneic Stem Cell Therapy Market, By Application
8.2 Autologous Market

9 Global Stem Cell Therapy Market – By Cell Source
9.1 Adipose Tissue-Derived Mesenchymal Stem Cells
9.2 Bone Marrow-Derived Mesenchymal Stem Cells
9.3 Cord Blood/Embryonic Stem Cells
9.4 Others

10 Global Stem Cell Therapy Market – By Therapeutic Application
10.1 Cardiovascular Diseases
10.2 Surgeries
10.3 Musculoskeletal Disorders
10.4 Wounds and Injuries
10.5 Gastrointestinal Diseases
10.6 Others

11 Global Stem Cell Therapy Market – By Geography (Market Size – & million/billion)
11.1 Introduction
11.2 North America
11.2.1 US
11.2.2 Canada
11.2.3 Mexico
11.3 Europe
11.3.1 U.K
11.3.2 Germany
11.3.3 Italy
11.3.4 France
11.3.5 Spain
11.3.6 Rest of Europe
11.4 Asia-Pacific
11.4.1 China
11.4.2 Japan
11.4.3 India
11.4.4 South Korea
11.4.5 Rest of APAC
11.5 Rest of the World
11.5.1 South America
11.5.2 Middle East
11.5.3 Africa

12 Global Stem Cell Therapy Market – Entropy
12.1 New product launches
12.2 M&A’s, collaborations, JVs and partnerships

13 Global Stem Cell Therapy Market -Company Profile (Key Players)
13.1 Market Share, Company Revenue, Products, M&A, Developments
13.2 Osiris Therapeutics, Inc.
13.3 MEDIPOST Co., Ltd.
13.4 Anterogen Co., Ltd.
13.5 RTI Surgical, Inc.
13.6 Allosource
13.7 Cellectis
13.8 Pharmicell Co., Ltd.
13.9 Holostem Terapie Avanzate SRL
13.10 JCR Pharmaceuticals Co., Ltd.
13.11 NuVasive, Inc.
13.12 Company 11 & more

14 Global Stem Cell Therapy Market – Appendix
14.1 Sources
14.2 Abbreviations